Thursday, April 18, 2024
12:00pm - 1:00pm
Hybrid Attendance: Research Bldg. 6, 1.206 Auditorium
or
Zoom
https://zoom.us/j/93312610364?pwd=czFySUFTRjYrajZwaVhsczVVSWpmUT09
Presenters
Jochen Reiser, MD, PhD
President
CEO, UTMB Health System
Professor, John Sealy School of Medicine
John D. Stobo, MD Distinguished Chair
The Path is the Goal: Physician-Science and a Potential New Drug for Kidney Disease
Objectives: At this conclusion of this presentation, participants should be able to:
- Move/translate the vital knowledge from researchers to clinicians, who are in position to help patients
- Use his/her discoveries to help people better their lives
Target Audience and Needs: Internal Medicine faculty, staff, registered nurses, residents, fellows, students, and internists specializing in Allergy & Immunology, Cardiology, Endocrinology, Gastroenterology, General Medicine,
Geriatrics, Hematology & Oncology, Infectious Diseases, Nephrology, Palliative Care, Pulmonary Critical Care & Sleep Medicine, and Rheumatology need to be regularly updated with new research and guidelines regarding the evaluation
and management of medical disorders and implement them in clinical practice to enhance the quality of patient care and improve patient outcomes.
Educational Methods: Educational methods will include lectures, case presentations, literature review, and panel discussion.
Activity Evaluation: Participants may be asked to complete a session evaluation.
Financial Disclosure: The following are reports of relationships with commercial interests by those individuals who are in the position to control the content of this activity.
Drs. Mujtaba and Ngutn does not have financial disclosures to provide:
Accreditation/Credit Designation: The University of Texas Medical Branch is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas Medical Branch designates this live activity for a maximum of _1_ AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Everyone is welcome.